China Shineway Pharmaceutical Group Ltd ADR (CSWYY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

China Shineway Pharmaceutical Group Ltd ADR (CSWYY) is up 7.0% since the beginning of the year. At $19 per share, CSWYY is trading just below its 52-week high of $19. Investors who bought $1,000 worth of CSWYY shares 5 years ago would now be looking at an investment worth $1,220.

China Shineway Pharmaceutical Group Ltd ADR (CSWYY) has returned 7.03% so far this year and 7.03% over the past 12 months.

Based on dividend-adjusted daily data since Jul 22, 2020, CSWYY's average daily return is +0.05%, while the average monthly return is +0.79%. At this rate, an investment would double in approximately 7.3 years.

Historically, 17% of months were positive and 83% were negative. The best month was Jan 2023 with a return of +55.1%, while the worst month was Sep 2022 at -42.2%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 2 months.

On a daily basis, CSWYY closed higher 4% of trading days. The best single day was Jan 24, 2023 with a return of +54.8%, while the worst single day was Sep 20, 2022 at -38.6%.

China Shineway Pharmaceutical Group Ltd ADR has an annualized alpha of 11.67%, beta of 0.02, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since July 22, 2020.

• This stock participated in 66.59% of S&P 500 Index downside but only 44.36% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.02 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CSWYY ranks 71 for risk / return — better than 71% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

China Shineway Pharmaceutical Group Ltd ADR provided a 8.20% dividend yield over the last twelve months, with an annual payout of $1.55 per share.

The table displays the monthly dividend distributions for China Shineway Pharmaceutical Group Ltd ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the China Shineway Pharmaceutical Group Ltd ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the China Shineway Pharmaceutical Group Ltd ADR was 45.23%, occurring on Oct 14, 2022. Recovery took 162 trading sessions.

The current China Shineway Pharmaceutical Group Ltd ADR drawdown is 16.57%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of China Shineway Pharmaceutical Group Ltd ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how China Shineway Pharmaceutical Group Ltd ADR is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.